1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Oncology Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Oncology Market, Germany
3.1 Oncology Market, Germany, Revenue ($m), 2018-2033
3.1.1 ALK Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
3.1.2 BCR-ABL Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
3.1.3 BRAF Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
3.1.4 BRCA Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
3.1.5 Colorectal Cancer Screening Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
3.1.6 EGFR Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
3.1.7 HER2 Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
3.1.8 KRAS Tests Market, Germany, Revenue ($m), by Segment, 2018-2033
3.2 Oncology Market, Germany, Volume (Units), 2018-2033
3.2.1 ALK Tests Market, Germany, Volume (Units), by Segment, 2018-2033
3.2.2 BCR-ABL Tests Market, Germany, Volume (Units), by Segment, 2018-2033
3.2.3 BRAF Tests Market, Germany, Volume (Units), by Segment, 2018-2033
3.2.4 BRCA Tests Market, Germany, Volume (Units), by Segment, 2018-2033
3.2.5 Colorectal Cancer Screening Tests Market, Germany, Volume (Units), by Segment, 2018-2033
3.2.6 EGFR Tests Market, Germany, Volume (Units), by Segment, 2018-2033
3.2.7 HER2 Tests Market, Germany, Volume (Units), by Segment, 2018-2033
3.2.8 KRAS Tests Market, Germany, Volume (Units), by Segment, 2018-2033
3.3 Oncology Market, Germany, Average Price ($) , 2018-2033
3.4 Oncology Market, Germany, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in Germany, Oncology Market
4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 Agilent Technologies Inc
4.2.1 Company Overview
4.3 Qiagen NV
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
4.5 Danaher Corp
4.5.1 Company Overview
4.6 Eiken Chemical Co Ltd
4.6.1 Company Overview
4.7 Amoy Diagnostics Co Ltd
4.7.1 Company Overview
4.8 ZytoVision GmbH
4.8.1 Company Overview
4.9 BioGenex Laboratories Inc
4.9.1 Company Overview
4.10 SENTINEL CH SpA
4.9.1 Company Overview
5 Oncology Market Pipeline Products6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 Merck KGaA Raises USD890.2 Million in Public Offering of 3.875% Bonds Due 2054
6.2 Partnerships
6.2.1 Life Technologies Enters into Co-Development Agreement with Thermo Fisher Scientific
6.2.2 EDX Medical Enters into Distribution Agreement with miRdetect
6.2.3 A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix
6.3 Venture Financing
6.3.1 Heidelberg Epignostix Secures USD4.6 Million in Seed Funding
7 Recent Developments
7.1 Corporate Communications
7.1.1 Mar 03, 2025: AI Diagnostic Platform Improves Early Detection of Skin Cancer
7.2 Other Significant Developments
7.2.1 May 19, 2025: Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology
7.2.2 Mar 10, 2025: Longevity Life Advisors Launches CancerEDGE: A Program Offering Advanced Cancer Genomics and Precision Health Services
7.3 Product News
7.3.1 Mar 03, 2025: AI Diagnostic Platform Improves Early Detection of Skin Cancer
7.3.2 Nov 11, 2024: Report Published by Research Journal, Germany’s Springer Concluded that TruScreen Cervical Cancer Screening Results were Comparable and Better than conventional LBC
7.3.3 Oct 17, 2024: Medigene Presents UniTope and TraCR a Universal Detection System for 3S Recombinant TCRs at ASGCT 2024
7.3.4 Jul 15, 2024: Peptomyc S.L. Expands Patent Portfolio with European and Indian Patent Grant for its Methods and Composition for the Treatment of Cancer
7.4 Strategy And Business Planning
7.4.1 Apr 22, 2025: ConcertAI Signs Strategic Agreement With Bayer
7.4.2 Mar 04, 2025: Tower Health, Siemens Healthineers Launch 10-Year Value Partnership to Advance Precision Imaging and Patient Care
7.4.3 Dec 05, 2024: IVDR-Certified FISH Probe Portfolio Expands to 95 Probes
7.4.4 Nov 26, 2024: Siemens Healthineers and The Ohio State Wexner Medical Center Expand Existing Strategic Relationship
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Oncology Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 2: ALK Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 3: BCR-ABL Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 4: BRAF Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 5: BRCA Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 6: Colorectal Cancer Screening Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 7: EGFR Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 8: HER2 Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 9: KRAS Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 10: Oncology Market, Germany, Volume (Units), 2018-2033
Table 11: ALK Tests Market, Germany, Volume (Units), 2018-2033
Table 12: BCR-ABL Tests Market, Germany, Volume (Units), 2018-2033
Table 13: BRAF Tests Market, Germany, Volume (Units), 2018-2033
Table 14: BRCA Tests Market, Germany, Volume (Units), 2018-2033
Table 15: Colorectal Cancer Screening Tests Market, Germany, Volume (Units), 2018-2033
Table 16: EGFR Tests Market, Germany, Volume (Units), 2018-2033
Table 17: HER2 Tests Market, Germany, Volume (Units), 2018-2033
Table 18: KRAS Tests Market, Germany, Volume (Units), 2018-2033
Table 19: Oncology Market, Germany, Average Price ($), 2018-2033
Table 20: Oncology Market, Germany, Company Share by Revenue ($m), 2024
Table 21: Oncology Market Pipeline Products
Table 22: Merck KGaA Raises USD890.2 Million in Public Offering of 3.875% Bonds Due 2054
Table 23: Life Technologies Enters into Co-Development Agreement with Thermo Fisher Scientific
Table 24: EDX Medical Enters into Distribution Agreement with miRdetect
Table 25: A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix
Table 26: Heidelberg Epignostix Secures USD4.6 Million in Seed Funding
Table 27: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Oncology Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 2: ALK Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 3: BCR-ABL Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 4: BRAF Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 5: BRCA Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 6: Colorectal Cancer Screening Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 7: EGFR Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 8: HER2 Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 9: KRAS Tests Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 10: Oncology Market, Germany, Volume (Units), 2018-2033
Figure 11: ALK Tests Market, Germany, Volume (Units), 2018-2033
Figure 12: BCR-ABL Tests Market, Germany, Volume (Units), 2018-2033
Figure 13: BRAF Tests Market, Germany, Volume (Units), 2018-2033
Figure 14: BRCA Tests Market, Germany, Volume (Units), 2018-2033
Figure 15: Colorectal Cancer Screening Tests Market, Germany, Volume (Units), 2018-2033
Figure 16: EGFR Tests Market, Germany, Volume (Units), 2018-2033
Figure 17: HER2 Tests Market, Germany, Volume (Units), 2018-2033
Figure 18: KRAS Tests Market, Germany, Volume (Units), 2018-2033
Figure 19: Oncology Market, Germany, Company Share (%), 2024